recent
past
wit
emerg
mani
new
infecti
diseas
major
public
health
threat
public
health
threat
pose
emerg
diseas
well
describ
report
institut
medicin
sinc
outbreak
legionella
aid
later
demonstr
due
hiv
mani
emerg
infecti
diseas
import
infect
control
implic
review
focu
sever
import
current
infect
prevent
threat
includ
ebola
viru
middl
eastern
respiratori
syndrom
mer
coronaviru
cov
carbapenemresist
enterobacteriacea
cre
candida
auri
focu
mechan
transmiss
environment
contamin
stabil
germicid
suscept
germicid
discuss
includ
chemic
steril
use
process
critic
equip
devic
eg
surgic
instrument
implant
highlevel
disinfect
use
disinfect
semicrit
equip
devic
ie
medic
equip
devic
come
contact
nonintact
skin
mucou
membran
lowlevel
disinfect
use
disinfect
surfac
share
equip
come
contact
intact
skin
eg
blood
pressur
cuff
room
surfac
antisept
ie
germicid
use
skin
mucou
membran
reduc
microbi
flora
review
updat
previou
articl
review
ebola
mer
also
review
cre
c
auri
world
health
organ
state
emerg
diseas
one
appear
popul
first
time
may
exist
previous
rapidli
increas
incid
geograph
rang
center
diseas
control
prevent
cdc
provid
follow
definit
emerg
infect
infecti
diseas
whose
incid
human
increas
past
decad
threaten
increas
near
futur
defin
emerg
diseas
respect
nation
boundari
includ
new
infect
result
chang
evolut
exist
organ
known
infect
spread
new
geograph
area
popul
previous
unrecogn
infect
appear
area
undergo
ecolog
transform
old
infect
reemerg
result
antimicrobi
resist
known
agent
breakdown
public
health
measur
factor
lead
emerg
infecti
diseas
describ
importantli
author
note
continu
see
new
emerg
infecti
diseas
forese
futur
recent
articl
provid
recommend
prepared
health
care
facil
local
nation
level
assess
manag
threat
emerg
infecti
diseas
requir
understand
biolog
pathogen
epidemiolog
clinic
manifest
infect
method
diagnosi
therapi
avail
health
care
facil
highli
communic
diseas
plan
agent
transmit
droplet
aerosol
eg
sever
acut
respiratori
syndrom
sar
mer
transmit
contact
eg
ebola
lassa
detail
inform
best
found
especi
earli
epidem
web
page
local
state
health
depart
cdc
highli
communic
diseas
major
area
place
health
care
facil
personnel
substanti
risk
diseas
acquisit
transmiss
first
inadequ
screen
procedur
patient
enter
health
care
facil
potenti
allow
transmiss
ill
patient
health
care
personnel
patient
visitor
second
inadequ
suppli
person
protect
equip
ppe
andor
train
health
care
personnel
hcp
proper
don
dof
procedur
increas
risk
exposur
hcp
key
focu
articl
review
transmiss
rout
new
emerg
infecti
agent
prevent
diseas
acquisit
via
persontoperson
transmiss
contact
contamin
environ
depend
rapid
appropri
institut
isol
precaut
appropri
hand
hygien
appropri
disinfect
medic
equip
devic
surfac
environ
importantli
natur
emerg
diseas
known
ie
envelop
viru
bacteria
fungi
nonenvelop
viru
mycobacteria
possibl
determin
proper
antisept
disinfect
even
absenc
studi
exact
infecti
agent
exampl
envelop
viru
eg
ebola
merscov
veget
bacterium
eg
cre
would
inactiv
agent
activ
nonenvelop
virus
mycobacteria
import
rememb
alcohol
reduc
activ
nonenvelop
virus
eg
noroviru
activ
spore
eg
clostridioid
difficil
first
recogn
outbreak
ebola
occur
west
africa
year
sinc
initi
outbreak
zair
sudan
outbreak
occur
largest
outbreak
occur
west
africa
guinea
sierra
leon
liberia
result
case
death
importantli
outbreak
hcp
develop
confirm
probabl
ebola
viru
diseas
evd
percentag
expos
hcp
develop
evd
rang
mortal
hcp
develop
ebola
frequent
exceed
key
concern
hcp
includ
low
inocul
dose
requir
transmiss
high
frequenc
hcp
infect
especi
resourc
poor
countri
high
mortal
evd
outbreak
continu
moder
intens
democrat
republ
congo
overal
peopl
treat
ebola
unit
state
epidem
two
hcp
care
patient
evd
unit
state
develop
evd
recov
microbiolog
epidemiolog
diagnosi
clinic
featur
treatment
ebola
review
ebola
caus
nonseg
singlestrand
neg
rna
viru
famili
filovirida
identifi
ebola
viru
speci
known
caus
diseas
human
zair
sudan
tai
forest
formerli
cote
divoir
bundibugyo
fifth
reston
viru
caus
diseas
nonhuman
primat
human
natur
reservoir
host
ebola
viru
remain
unknown
howev
detect
antibodi
ebola
ebola
viru
fragment
fruitand
insectivor
bat
highli
suggest
anim
serv
reservoir
evd
character
sudden
onset
fever
headach
myalgia
arthralgia
larg
joint
back
pain
typic
day
initi
symptom
gastrointestin
symptom
occur
includ
abdomin
pain
nausea
vomit
diarrhea
macular
maculopapular
skin
rash
may
appear
day
diseas
hemorrhag
less
common
occur
patient
termin
case
develop
dissemin
intravascular
coagul
septic
shock
multiorgan
system
failur
mortal
rang
depend
part
infect
strain
ebola
transmit
persontoperson
commonli
direct
contact
ie
nonintact
skin
via
mucou
membran
contact
blood
bodi
fluid
eg
urin
saliva
sweat
fece
vomit
breast
milk
semen
ill
person
indirectli
via
object
needl
syring
contamin
bodi
fluid
ill
person
tabl
less
common
mechan
includ
acquisit
infect
fruit
bat
nonhuman
primat
sexual
transmiss
also
describ
ebola
transmit
via
air
water
howev
africa
acquir
handl
bush
meat
incub
period
ebola
gener
day
rang
day
persontoperson
transmiss
occur
person
sign
symptom
evd
diagnost
test
achiev
use
real
time
rt
polymeras
chain
reaction
pcr
blood
viral
rna
usual
detect
pcr
day
onset
symptom
patient
evd
provid
appropri
critic
care
includ
fluid
electrolyt
replac
oxygen
therapi
maintain
oxygen
statu
medic
support
blood
pressur
reduc
vomit
diarrhea
manag
fever
pain
oral
parenter
nutrit
treat
coexist
infect
eg
malaria
present
although
current
antivir
drug
approv
us
food
drug
administr
fda
number
therapi
investig
includ
antibodybas
therapi
eg
convalesc
blood
product
monoclon
antibodi
drug
small
molecul
eg
ebola
viru
gene
express
inhibitor
ebola
viru
entri
inhibitor
number
prevent
vaccin
current
clinic
trial
environment
contamin
surviv
ebola
viru
isol
cell
cultur
multipl
bodi
fluid
infect
convalesc
patient
includ
blood
saliva
stool
vagin
fluid
sweat
urin
day
month
ill
given
high
volum
diarrhea
vomit
potenti
fomit
transmiss
frequenc
environment
contamin
surviv
ebola
viru
high
concern
sever
studi
assess
frequenc
contamin
within
health
care
rtpcr
although
frequenc
environment
contamin
variabl
studi
report
environment
sampl
posit
rtpcr
contamin
often
demonstr
blood
stain
item
toiletlatrin
object
close
proxim
patient
eg
mattress
bed
rail
sampl
ppe
eg
glove
test
posit
rtpcr
ebola
viru
viabl
viru
isol
either
studi
cultur
environment
sampl
environment
surviv
ebola
viru
studi
use
culturebas
techniqu
varieti
environment
condit
eg
temperatur
humid
variou
liquid
aerosol
surfac
studi
may
summar
follow
first
viabl
ebola
surviv
liquid
eg
liquid
media
tissu
cultur
media
water
liquid
blood
plasma
day
week
second
viabl
ebola
viru
also
surviv
dri
varieti
surfac
eg
plastic
glass
stainless
steel
polypropylen
nitril
bank
note
day
week
third
ebola
surviv
liquid
surfac
longer
durat
time
lower
temperatur
eg
vs
fourth
although
aerosol
transmiss
observ
ebola
viru
demonstr
surviv
aerosol
hour
fifth
surviv
ebola
porou
surfac
cotton
substanti
less
steel
plastic
surfac
use
macaqu
viabl
ebola
viru
demonstr
surviv
corps
least
day
rna
could
detect
tissu
entir
studi
period
ebola
viru
detect
rtpcr
deceas
patient
hous
day
patient
buri
consist
use
appropri
ppe
strict
adher
don
dof
protocol
crucial
prevent
acquisit
evd
patient
care
key
compon
reduc
hcp
risk
proper
train
ppe
don
dof
ongo
train
maintain
compet
ebola
viru
inactiv
deterg
use
rtpcr
cook
et
al
demonstr
ebola
viru
outbreak
variant
dri
organ
soil
load
stainless
steel
carrier
inert
minut
exposur
sodium
hypochlorit
minut
exposur
ethanol
smither
et
al
confirm
activ
sodium
hypochlorit
ebola
virus
measur
pcr
inactiv
sodium
hypochlorit
minut
contact
time
later
studi
smither
et
al
report
multipl
disinfect
ie
hypochlorit
hypochlorit
peracet
acid
ethanol
effect
dri
cell
cultur
medium
contain
ebola
viru
howev
peracet
acid
consist
reduc
ebola
viru
titer
dri
blood
undetect
level
base
hierarchi
microbi
suscept
germicid
studi
germicid
efficaci
cdc
state
us
environment
protect
agenc
epa
regist
hospit
disinfect
label
claim
nonenvelop
viru
eg
noroviru
rotaviru
adenoviru
use
disinfect
environment
surfac
room
patient
known
suspect
evd
systemat
review
kampf
report
ethanol
highli
effect
test
envelop
virus
within
second
reduct
ebola
strain
achiev
second
use
follow
povidoneiodin
solut
iodin
alcohol
therefor
data
suggest
hand
antisepsi
skin
contamin
ebola
viru
obtain
either
povidoneiodin
alcohol
although
proper
ppe
alway
worn
ultravioletlight
uvc
booth
demonstr
inactiv
bacteriophag
nonenvelop
viru
could
use
disinfect
contamin
ppe
histori
mer
review
mer
new
viral
respiratori
diseas
human
first
describ
later
discov
caus
novel
coronaviru
merscov
lineag
b
cov
report
decemb
laboratoryconfirm
case
mer
includ
associ
death
casefat
rate
report
global
although
case
report
countri
major
case
ie
report
saudi
arabia
two
case
mer
report
unit
state
health
care
provid
acquir
infect
saudi
arabia
transmiss
report
unit
state
microbiolog
epidemiolog
clinic
manifest
mer
review
merscov
betacoronaviru
singlestrand
positivesens
envelop
rna
viru
caus
acut
respiratori
ill
human
merscov
zoonot
diseas
transmit
animalstohuman
dromedari
camel
host
merscov
implic
direct
indirect
transmiss
human
although
exact
mode
transmiss
unknown
bat
like
main
mammalian
reservoir
clinic
spectrum
mer
infect
rang
asymptomat
mild
respiratori
symptom
sever
acut
respiratori
diseas
death
typic
symptom
mer
includ
fever
cough
short
breath
pneumonia
common
alway
present
gastrointestin
symptom
vomit
diarrhea
frequent
occur
risk
factor
sever
diseas
includ
older
age
comorbid
eg
chronic
lung
diseas
diabet
immunosuppress
diagnosi
confirm
posit
rtpcr
assay
target
least
differ
genom
region
current
specif
therapi
vaccin
avail
mer
may
transmit
persontoperson
via
direct
contact
like
due
droplet
transmiss
tabl
occur
commonli
close
contact
provid
unprotect
care
infect
patient
thu
far
sustain
commun
transmiss
document
studi
famili
cluster
hcp
contact
patient
report
low
frequenc
transmiss
ie
howev
increas
transmiss
occur
health
care
set
limit
infect
control
procedur
importantli
mer
may
transmit
asymptomat
sourc
howev
super
spreader
also
report
epidemiolog
prevent
mer
health
care
set
review
infect
prevent
strategi
inform
multipl
report
outbreak
mer
involv
health
care
facil
larg
outbreak
south
korea
importantli
outbreak
case
may
occur
health
care
provid
factor
contribut
intrahospit
transmiss
includ
initi
symptom
mer
nonspecif
extens
environment
contamin
document
cultur
rtpcr
clinic
area
hous
mer
patient
posit
site
includ
patient
room
surfac
eg
bed
sheet
bedrail
intraven
fluid
hanger
anteroom
surfac
medic
devic
eg
portabl
xray
machin
thermomet
airventil
equip
touchabl
surfac
found
contamin
respiratori
secret
clinic
fulli
recov
patient
merscov
also
detect
air
sampl
vicin
patient
howev
larg
outbreak
evalu
fail
demonstr
transmiss
via
potenti
contamin
environ
without
direct
contact
index
case
merscov
shown
recover
hour
steel
plastic
washer
rel
humid
decreas
stabil
observ
aerosol
experi
multipl
studi
cov
merscov
demonstr
virus
remain
viabl
day
week
environment
surfac
surviv
enhanc
low
temperatur
ie
vs
merscov
envelop
viru
like
suscept
eparegist
hospit
disinfect
fdaapprov
antisept
studi
inactiv
surrog
sarscov
mous
hepat
viru
transmiss
gastroenter
viru
demonstr
follow
inactiv
contact
time
transmiss
gastroenter
viru
log
reduct
factor
ethanol
phenol
orthophthalaldehyd
hypochlorit
ethanol
ethanol
mous
hepat
viru
log
reduct
factor
ethanol
phenol
orthophthalaldehyd
hypochlorit
ethanol
ethanol
guidanc
cdc
manag
patient
mer
state
hcp
perform
hand
hygien
patient
contact
contact
potenti
infecti
materi
put
upon
remov
ppe
includ
glove
hand
hygien
healthcar
set
perform
wash
soap
water
use
alcoholbas
hand
rub
hand
visibl
soil
use
soap
water
alcoholbas
handrub
cdc
state
standard
clean
disinfect
procedur
eg
use
cleaner
water
preclean
surfac
prior
appli
eparegist
disinfect
frequent
touch
surfac
object
appropri
contact
time
indic
product
label
appropri
merscov
healthcar
set
includ
patientcar
area
aerosolgener
procedur
perform
avail
eparegist
product
label
claim
merscov
product
label
claim
human
coronavirus
use
accord
label
instruct
cdc
defin
cre
surveil
purpos
enterobacteriacea
resist
imipenem
meropenem
doripenem
ertapenem
document
isol
possess
carbapenemas
cdc
elabor
cre
phenotyp
definit
ie
base
antibiot
suscept
pattern
organ
includ
bacteria
suscept
carbapenem
via
one
type
mechan
cdc
specifi
carbapenem
resist
mechan
includ
follow
product
carbapenemas
call
carbapenemaseproducingcr
enzym
break
carbapenem
relat
antimicrobi
make
ineffect
includ
enzym
like
klebsiella
pneumonia
carbapenemas
combin
mechan
carbapenemas
product
call
noncarbapenemaseproducingcr
commonli
product
blactamas
eg
ampc
combin
alter
bacteria
cell
membran
eg
porin
mutat
cdc
report
follow
type
cre
unit
state
ndm
vim
imp
klebsiella
pneumonia
carbapenemas
biolog
epidemiolog
manag
cre
review
recent
articl
review
newer
antibiot
therapi
cre
followup
hospit
cre
colon
patient
demonstr
mean
durat
colon
carriag
year
howev
hcp
rare
ever
colon
studi
fecal
carriag
among
hcp
hospit
endem
cre
reveal
none
evalu
health
care
provid
colon
cre
main
reservoir
lead
human
cre
infect
human
gut
persontoperson
transmiss
via
direct
indirect
contact
common
mechan
transmiss
tabl
multipl
hospit
outbreak
result
contamin
endoscop
especi
duodenoscop
outbreak
occur
despit
step
clean
highlevel
disinfect
endoscop
compliant
current
guidelin
strategi
provid
pathogenfre
endoscop
review
water
sourc
hospit
eg
faucet
wash
basin
shower
toilet
especi
sink
demonstr
reservoir
cre
strategi
success
rate
intervent
elimin
cre
water
reservoir
review
companion
anim
demonstr
occasion
colon
cre
relev
health
care
facil
consid
us
health
care
facil
must
permit
person
servic
anim
facil
mani
hospit
permit
animalassist
therapi
strategi
manag
cre
colonizedinfect
patient
control
outbreak
health
care
facil
review
cdc
provid
detail
guidanc
method
control
cre
use
bundl
control
horizont
transmiss
cre
health
care
facil
review
environment
contamin
surviv
cre
isol
environ
vicin
hospit
colonizedinfect
patient
includ
pillow
infus
pump
bedsid
tabl
toilet
area
frequenc
recoveri
vari
among
studi
object
closer
patient
like
contamin
sampl
bedrail
bed
tabl
yield
cre
fecal
contin
independ
predictor
nonspread
cre
cre
also
isol
environ
longterm
care
facil
havil
et
al
report
surviv
cre
stainless
steel
disc
day
howev
weber
et
al
report
speci
cre
klebsiella
enterobact
escherichia
coli
surviv
poorli
dieoff
hour
like
differ
owe
fact
havil
et
al
use
high
inoculum
ie
wherea
weber
use
low
inoculum
ie
similar
actual
amount
cre
found
surfac
vicin
patient
colon
infect
cre
rare
possibl
except
antibioticresist
bacteria
includ
multidrugresist
organ
reduc
suscept
eparegist
germicid
even
reduc
suscept
germicid
eg
quaternari
ammonium
compound
methicillinresist
staphylococcu
aureu
mrsa
demonstr
pathogen
demonstr
resist
use
concentr
germicid
kanamori
et
al
assess
efficaci
germicid
multipl
cre
enterobacteriacea
strain
contact
time
presenc
fetal
calf
serum
four
highlevel
disinfect
achiev
kill
test
strain
orthophthalaldehyd
achiev
kill
depend
cre
strain
test
eight
disinfect
achiev
kill
among
antisept
test
ethanol
povidoneiodin
chlorhexidin
glucon
isopropyl
alcohol
chloroxylenol
achiev
kill
test
cre
strain
base
studi
eparegist
disinfect
fdaapprov
antisept
use
assur
equip
instrument
highlevel
disinfect
surfac
disinfect
hand
antisepsi
uvc
devic
room
disinfect
shown
inactiv
cre
reduct
direct
line
sight
cre
reduct
indirect
line
sight
use
recommend
cycl
time
ie
minut
effect
uvc
room
disinfect
confirm
anoth
studi
histori
microbiolog
c
auri
novel
candida
speci
first
report
follow
isol
ear
canal
patient
japan
sinc
c
auri
report
multipl
countri
throughout
world
cdc
report
januari
case
c
auri
report
state
state
ie
new
york
illinoi
new
jersey
report
case
c
auri
emerg
pathogen
present
seriou
global
health
threat
follow
reason
caus
seriou
infect
high
mortal
often
difficult
identifi
standard
laboratori
method
misidentifi
laboratori
unless
special
technolog
use
often
multidrug
resist
intrins
rapidli
induc
antifung
resist
becom
widespread
geograph
increas
preval
biofilm
format
persist
environ
caus
multipl
outbreak
health
care
facil
microbiolog
clinic
syndrom
diagnosi
treatment
c
auri
review
genet
analys
shown
c
auri
close
relat
c
lusitania
c
haemulonii
although
strike
diverg
candida
speci
c
auri
often
misidentifi
convent
diagnost
laboratori
use
biochem
type
c
auri
commonli
misidentifi
c
haemulonii
also
c
famata
c
sake
rhodotorula
glutini
r
mucilaginosa
saccharomyc
boulardii
current
accur
identif
c
auri
accomplish
use
malditof
pcr
assay
specif
c
auri
multipl
virul
factor
describ
common
clinic
syndrom
report
bloodstream
infect
candidemia
wound
infect
ear
infect
clinic
syndrom
report
includ
infect
respiratori
tract
central
nervou
system
urogenit
system
intraabdomin
skin
soft
tissu
bone
patient
c
auri
infect
almost
alway
present
underli
ill
comorbid
diabet
chronic
acut
renal
failur
pulmonari
diseas
immunosuppress
condit
tumor
malign
liver
diseas
solid
organ
transplant
risk
factor
infect
usual
includ
care
intens
care
unit
presenc
indwel
central
venou
cathet
arteri
line
foley
cathet
invas
surgic
procedur
mechan
ventil
prior
continu
exposur
broadspectrum
antibiot
antifung
agent
mortal
rate
report
patient
invas
infect
present
time
clinic
breakpoint
c
auri
high
minimum
inhibitori
concentr
report
fluconazol
triazol
antifung
voriconazol
itraconazol
isavaconazol
variabl
suscept
isol
also
report
amphotericin
epidemiolog
transmiss
c
auri
associ
multipl
nosocomi
outbreak
especi
intens
care
set
evalu
c
auri
new
york
citi
health
care
facil
demonstr
epidemiolog
link
case
multipl
hospit
longterm
care
facil
importantli
colon
c
auri
detect
multipl
bodi
site
includ
nare
groin
axilla
rectum
prolong
colon
report
c
auri
detect
month
initi
isol
despit
multipl
neg
screen
antifung
therapi
multipl
mechan
transmiss
c
auri
like
base
outbreak
investig
tabl
risk
factor
colon
infect
report
includ
contact
patient
known
harbor
c
auri
share
environ
c
auri
patient
sequenti
bed
occup
previous
occupi
patient
c
auri
also
describ
risk
importantli
patient
occupi
room
previous
hous
patient
c
auri
acquir
c
auri
even
though
room
decontamin
prior
occup
outbreak
evalu
found
use
reusabl
probe
temperatur
monitor
associ
significantli
increas
risk
c
auri
colon
odd
ratio
transmiss
c
auri
via
transplant
lung
patient
respiratori
tract
colon
infect
lung
transplant
recipi
report
c
auri
occasion
isol
health
care
provid
biswal
et
al
report
c
auri
detect
hand
tabl
mode
transmiss
candida
auri
patienttopati
via
direct
contact
patienttopati
via
indirect
contact
due
environment
contamin
ie
share
hospit
room
admiss
hospit
room
previous
occupi
patient
c
auri
less
common
patienttopati
via
indirect
contact
share
equip
due
inadequ
disinfect
eg
thermomet
patienttopati
via
direct
contact
donorderiv
transmiss
eg
lung
transplant
persontoperson
via
indirect
contact
due
transient
colon
health
care
provid
hand
health
care
provid
although
like
due
inadequ
hand
hygien
rather
longterm
colon
schelenz
et
al
conduct
outbreak
investig
unit
kingdom
screen
nose
axilla
groin
throat
health
care
provid
colon
found
singl
person
nurs
transient
colon
c
auri
widespread
contamin
surfac
environ
report
multipl
investig
importantli
contamin
site
includ
site
patient
room
surfac
toilet
ventilatorrespiratori
equip
site
outsid
patient
room
comput
workstat
thermomet
glucomet
housekeep
cart
dialysi
equip
ultrasound
equip
vital
sign
machin
environment
surviv
c
auri
studi
laboratori
test
c
auri
candida
spp
demonstr
persist
day
moist
dri
steel
disk
surfac
surviv
dri
linen
day
demonstr
c
auri
cell
demonstr
remain
viabl
plastic
surfac
least
week
week
longer
cultur
sever
review
includ
discuss
suscept
c
auri
germicid
suscept
c
auri
germicid
ie
antisept
disinfect
studi
sever
investig
rutala
et
al
assess
germicid
activ
highlevel
disinfect
andor
chemic
steril
report
agent
ie
peracet
acid
glutaraldehyd
hydrogen
peroxid
plu
peroxyacet
acid
acceler
hydrogen
peroxid
achiev
reduct
c
auri
except
orthophthalaldehyd
achiev
inactiv
e
coli
importantli
vitro
experi
done
challeng
condit
ie
fetal
calf
serum
exposur
time
like
highlevel
disinfect
current
approv
fda
use
appropri
ie
appropri
clean
manufactur
recommend
concentr
durat
effect
c
auri
activ
lowlevel
disinfect
evalu
sever
investig
direct
comparison
studi
imped
use
differ
test
condit
includ
test
method
durat
exposur
presenc
absenc
protein
fetal
calf
serum
activ
lowlevel
disinfect
comprehens
investig
use
discbas
quantit
carrier
test
summar
tabl
importantli
investig
ad
fetal
calf
serum
assess
germicid
efficaci
stringent
condit
ie
presenc
protein
importantli
quaternari
ammonium
disinfect
alon
significantli
less
effect
c
auri
product
investig
report
concentr
sodium
hypochlorit
ppm
effect
kill
c
auri
minut
wherea
other
report
sodium
hypochlorit
ppm
exposur
time
minut
result
reduct
c
auri
unclear
whether
longer
exposur
time
lack
protein
load
led
high
reduct
rate
report
abdolrasouli
et
al
moor
et
al
howev
investig
report
dilut
sodium
hypochlorit
effect
kill
c
auri
even
short
exposur
time
ie
minut
presenc
protein
base
current
studi
cdc
state
quaternari
ammonium
compound
qac
routin
use
disinfect
may
effect
c
auri
inform
avail
c
auri
cdc
recommend
use
environment
protect
agenc
epa
regist
hospitalgrad
disinfect
effect
clostridium
difficil
spore
list
k
cdc
state
use
product
list
k
feasibl
publish
research
found
follow
product
led
substanti
reduct
room
disinfect
uvc
devic
investig
abil
inactiv
candida
spp
mrsa
clo
difficil
c
auri
demonstr
substanti
less
suscept
uvc
mrsa
less
suscept
c
albican
c
glabrata
minut
exposur
time
reduct
c
auri
clo
difficil
similar
minut
regard
room
disinfect
devic
cdc
state
data
handsfre
disinfect
method
like
germicid
uv
irradi
limit
method
may
requir
cycl
time
similar
use
inactiv
bacteri
spore
eg
clostridium
difficil
use
c
auri
recommend
daili
termin
room
cleaningdisinfect
done
agent
demonstr
effect
c
auri
use
uvc
devic
termin
disinfect
consid
supplement
method
activ
antisept
c
auri
studi
sever
investig
tabl
good
agreement
alcohol
isopropyl
ethyl
effect
c
auri
minut
importantli
activ
alcohol
studi
time
use
health
care
provid
perform
hand
hygien
ie
second
unfortun
studi
activ
import
antisept
chlorhexidin
glucon
povidoneiodin
produc
variabl
result
tabl
variabl
like
explain
differ
test
condit
includ
vitro
versu
human
challeng
durat
exposur
presenc
protein
load
eg
fetal
calf
serum
appear
povidoneiodin
would
provid
adequ
skin
antisepsi
appli
minut
use
panel
c
auri
clinic
isol
kean
et
al
screen
plankton
sessil
suscept
skin
disinfect
challeng
use
povidoneiodin
chlorhexidin
glucon
hydrogen
peroxid
c
auri
biofilm
display
increas
toler
antisepsi
compar
plankton
cell
analysi
use
complex
biofilm
model
demonstr
reduc
suscept
clinic
relev
concentr
chlorhexidin
glucon
hydrogen
peroxid
erad
achiev
povidoneiodin
note
forsberg
et
al
whether
topic
antisept
might
reduc
burden
c
auri
skin
therefor
provid
potenti
valuabl
tool
infect
prevent
remain
unclear
cdc
state
care
patient
c
auri
healthcar
personnel
follow
standard
hand
hygien
practic
includ
alcoholbas
hand
sanit
use
hand
visibl
soil
wash
soap
water
wear
glove
substitut
hand
hygien
